Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
Enregistré dans:
Auteurs principaux: | John C Morris, Susan L Stark, Rebecca M Bollinger, Audrey Keleman, Regina Thompson, Elizabeth Westerhaus, Anne M Fagan, Tammie LS Benzinger, Suzanne E Schindler, Chengjie Xiong, David Balota, Beau M Ances |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMJ Publishing Group
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/48f5aaf10d1c432faa119e41b4653dbe |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
par: Stephan Müller, et autres
Publié: (2017) -
Where We Fall Down: Tensions in Teaching Social Medicine and Global Health
par: Amy Finnegan, et autres
Publié: (2017) -
Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
par: Kathryn Goozee, et autres
Publié: (2017) -
Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature
par: Samuel Asanad, et autres
Publié: (2021) -
Disease progression modelling from preclinical Alzheimer’s disease (AD) to AD dementia
par: Soo Hyun Cho, et autres
Publié: (2021)